drugset / Trial / NCT01587430

3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia

NCT01587430

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal: to evaluate the role of high dose ara-c plus idarubicin and mitoxantrone consolidation followed by maintenance in the setting of high total cumulative anthracyclines dose(720-660 mg/m2).

Timeline

Start
2010-01
Primary completion
2014-04
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cytarabine Small molecule 1 g
Comparator Cytarabine Small molecule 100 g
Comparator Daunorubicin Small molecule
Comparator Idarubicin Small molecule 8 mg/m2
Comparator Mitoxantrone Small molecule 10 mg/m2